Endobronchial valve implantation for emphysema. Update 2018

Wild C
Record ID 32018000316
Original Title: Endobronchiale Ventilimplantation bei Lungenemphysem. Update 2018
Authors' objectives: Endobronchial valve implantation in patients with severe pulmonary emphysema aims to alleviate disease-related symptoms, prevent deterioration of lung function and improve quality of life.
Authors' recomendations: The available evidence suggests that the investigated intervention "endobronchial valve implantation in selected patients with severe pulmonary emphysema" is more effective but less safe than drug therapy.
Authors' methods: The 4th update is based on the results of the Cochrane Review "Bronchoscopic lung volume reduction procedure for chronic obstructive pulmonary disease" (2017): A total of 5 RCTs were evaluated in meta-analyses (703 patients).
Project Status: Completed
Year Published: 2018
URL for additional information: http://eprints.aihta.at/1166/
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Austria
MeSH Terms
  • Therapeutics
  • Surgical Procedures, Operative
  • Minimally Invasive Surgical Procedures
  • Emphysema
  • Lung Diseases, Obstructive
  • Endobronchial valve implantation
  • emphysema
  • lung volume reduction
  • chronic obstructive pulmonary disease
  • COPD
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.